Health knowledge made personal
Join this community!
› Share page:
Search posts:

Study: MRSA Infections Treated With Colostrum and Whey (UPDATED)

Posted Sep 14 2008 4:08pm 1 Comment

(Posted by Patrick Sullivan Jr.)

For the diehard science readers of this blog, take a look the latest study with MRSA infections and Ai/e10, which is the active component of Cyto-Ess Immune Support, a bio-engineered lacteal complex. This was published last Friday in the Journal of Immunopharmacology.

Study: A Pilot Study of an anti-MRSA Bio-Engineered Lacteal Complex (anti-MRSA BLC) in a Murine Septicemia Model

Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen of humans and other animals, causing septicemia, abcessation, toxemia, and other infectious diseases. Refined bioengineered lacteal complex (BLC), made specifically against MRSA, is a novel complex of low molecular weight immunogenic and antimicrobial molecules. It was evaluated in vivo using a mouse model of MRSA-induced peritonitis.

Intraperitoneal dosing of anti-MRSA BLC demonstrated a therapeutic effect (83% survival) against an intraperitoneal MRSA challenge that caused 100% mortality in untreated animals. Anti-MRSA BLC is a promising therapeutic modality for MRSA infection.

Methicillin-resistant Staphylococcus aureus (MRSA) is an increasingly common cause of life- and limb-threatening infections throughout the world.(1–3) It is now one of the most common causes of nosocomial and community-acquired infections and has developed a stable resistance to many antibiotics.(4) Since 1961, when MRSA was first reported as a clinical concern, it has become a serious problem with increasing numbers of cases and associated morbidity and mortality.(5,6)

A filtrate of colostrum and whey from antigen infused dairy cows has been used experimentally since the late 1950s in humans and animals.(7) Empirical and anecdotal evidence suggests enhanced immune-boosting properties compared with typical colostrum and whey products. From the beginning, this material appeared to restore immune function in people and animals suffering from conditions related to immune dysfunction including those suffering from acute, chronic, and degenerative diseases. Further research and development has yielded a novel (U.S. Patent Application No. 11/122,231) bioengineered lacteal complex (BLC) that utilizes new technology for its induction, purification, and characterization of molecular components. Anti-MRSA BLC contains specific, low molecular weight molecules that have antimicrobial properties against MRSA and also enhances immune function against MRSA infection.

The present study was undertaken to investigate in vivo effects of anti-MRSA BLC using an intraperitoneal systemic sepsis model.

Read the rest of the study.

UPDATE: The producer of Cyto-Ess emailed me the following important clarification.

Though the MRSA product discussed in the study employs technology we developed, the material is not Ai/E10 [Cyto-Ess]. It is in fact a very advanced and concentrated refined lacteal complex.

You might say "the BLC discussed in the study uses a technology similar to that used to produce the Ai/E10 that is included in Cyto-Ess and demonstrates the broad potential of refined lacteal complexes."

Thanks David, I think I'll say that exactly. :)

Comments (1)
Sort by: Newest first | Oldest first
this is a little over my head, but I have a reason to find out information, so I am trying.  Would human babies and adults benefit from drinking colostrum? My daughter has contracted MRSA and has a newborn.  Would her own milk help her fight this bacteria?
Post a comment
Write a comment:

Related Searches